Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Subin Valayil"'
Autor:
Thomas Frye, Minhaj Siddiqui, Peter A. Pinto, Bradford J. Wood, Mahir Maruf, Arvin K. George, Michael Kongnyuy, Baris Turkbey, J M DiBianco, Akhil Muthigi, P. L. Choyke, Amichai Kilchevsky, Subin Valayil, Abhinav Sidana, Michele Fascelli
Publikováno v:
Prostate Cancer Prostatic Dis
BACKGROUND: The Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPTRC) is a widely used risk-based calculator used to assess a man’s risk of prostate cancer (PCa) before biopsy. This risk calculator was created from data of a patient cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6e8c00ea3add8a6de7f6a0bb2ffb692
https://doi.org/10.1038/pcan.2016.46
https://doi.org/10.1038/pcan.2016.46
Autor:
Baris Turkbey, Francesca Mertan, Akhil Muthigi, Arvin K. George, Subin Valayil, Peter A. Pinto, Michael Kongnyuy
Publikováno v:
Abdom Radiol (NY)
Prostate cancer is unique in that unlike other solid organ malignancies, only recently has imaging been employed to routinely detect and localize disease. The introduction of transrectal ultrasound was a significant development, transitioning digital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f87ba99d8d4efc714c1c0448c4c7daf
https://doi.org/10.1007/s00261-016-0751-6
https://doi.org/10.1007/s00261-016-0751-6
Autor:
M. Minhaj Siddiqui, Akhil Muthigi, Peter L. Choyke, Abhinav Sidana, Amit Jain, Mahir Maruf, Arvin K. George, Brian Calio, Dordaneh Sugano, Subin Valayil, Peter A. Pinto, Thomas Frye, Michael Kongnyuy, Bradford J. Wood, Baris Turkbey
Publikováno v:
Journal of Urology. 197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb2784a129b7351d95e54a03b5c9cb0
https://doi.org/10.1016/j.juro.2017.02.1327
https://doi.org/10.1016/j.juro.2017.02.1327
Autor:
Bradford J. Wood, Peter A. Pinto, Abhinav Sidana, Subin Valayil, Mahir Maruf, Arvin K. George, Michael Kongnyuy, Akhil Muthigi
Publikováno v:
Urologic oncology. 35(1)
Introduction and objective Multiparametric magnetic resonance imaging (MRI) and magnetic resonance (MR) -targeted biopsy have a growing role in the screening and evaluation of prostate cancer. We aim to evaluate the current knowledge, attitude, and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03dbbdeabf6093ce4e55d6d21affdea2
https://pubmed.ncbi.nlm.nih.gov/27743850
https://pubmed.ncbi.nlm.nih.gov/27743850
Autor:
Subin Valayil, Akhil Muthigi, Matthew J. Watson, Peter A. Pinto, Michael Kongnyuy, Mahir Maruf, Arvin K. George, Thomas Frye
Publikováno v:
Future oncology (London, England). 12(21)
Accurate risk stratification of prostate cancer is achieved with a number of existing tools to ensure the identification of at-risk patients, characterization of disease aggressiveness, prediction of cancer burden and extrapolation of treatment outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a685a175906505e6a1daaa8627d0833f
https://pubmed.ncbi.nlm.nih.gov/27400645
https://pubmed.ncbi.nlm.nih.gov/27400645
Autor:
Akhil Muthigi, M. Minhaj Siddiqui, Baris Turkbey, Brian P. Calio, Bradford J. Wood, Amit Jain, Subin Valayil, Mahir Maruf, Arvin K. George, Thomas Frye, Michael Kongnyuy, Peter A. Pinto, Dordaneh Sugano, Abhinav Sidana, Raju Chelluri, Peter L. Choyke
Publikováno v:
Journal of Clinical Oncology. 35:59-59
59 Background: Pathologic progression is identified in > 25% of prostate cancer (CaP) patients on active surveillance (AS). Yet, identifying patients at risk for progression is limited to PSA based biomarkers with variable utility. Multiparametric MR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc7957cde61c41aaeb8c93b9827ed7b2
https://doi.org/10.1200/jco.2017.35.6_suppl.59
https://doi.org/10.1200/jco.2017.35.6_suppl.59